Patents Represented by Attorney Travis Young

Find this attorney in the Justia Lawyer Directory

  • Method for identifying compounds that modulate RXR associated processes with IgE production
    Patent number: 7604951
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a retinoid X receptor as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: October 20, 2009
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Todd M. Kinsella, Esteban Masuda, Mark K. Bennett, Justin E. Warner, David C. Anderson